CM Management
Latest statistics and disclosures from CM Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ARKO, ALCO, TGB, RLGT, FOLD, and represent 22.77% of CM Management's stock portfolio.
- Added to shares of these 10 stocks: RIGL, CPA, TALO, FCX, PK, HRI, PRGO, CHRS, JAZZ, COHU.
- Started 8 new stock positions in FCX, CPA, PRGO, PIRS, Os Therapies Incorporated, RIGL, FHN, HRI.
- Reduced shares in these 10 stocks: BIDU, BABA, NMRK, RVNC, HAS, CLPT, KHC, NWL, PAAS, VRNA.
- Sold out of its positions in BABA, BIDU, GANX, HAS, KHC, RVNC, VRNA.
- CM Management was a net buyer of stock by $8.8M.
- CM Management has $129M in assets under management (AUM), dropping by 14.88%.
- Central Index Key (CIK): 0001841857
Tip: Access up to 7 years of quarterly data
Positions held by CM Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for CM Management
CM Management holds 64 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Arko Corp (ARKO) | 5.5 | $7.2M | 1.0M | 7.02 |
|
|
Ali (ALCO) | 4.9 | $6.3M | 225k | 27.97 |
|
|
Taseko Cad (TGB) | 4.8 | $6.2M | 2.5M | 2.52 |
|
|
Radiant Logistics (RLGT) | 3.9 | $5.0M | 775k | 6.43 |
|
|
Amicus Therapeutics (FOLD) | 3.7 | $4.8M | 450k | 10.68 |
|
|
Rigel Pharmaceuticals (RIGL) | 3.6 | $4.7M | NEW | 290k | 16.18 |
|
Newmark Group Com - Class A (NMRK) | 3.6 | $4.7M | -25% | 300k | 15.53 |
|
Royalty Pharma Com - Class A (RPRX) | 3.5 | $4.5M | 160k | 28.29 |
|
|
Talos Energy (TALO) | 2.8 | $3.6M | +75% | 350k | 10.35 |
|
Preformed Line Products Company (PLPC) | 2.7 | $3.5M | +3% | 27k | 128.08 |
|
Clearpoint Neuro (CLPT) | 2.6 | $3.4M | -20% | 300k | 11.21 |
|
Kyndryl Holdings Ord Wi (KD) | 2.5 | $3.2M | 140k | 22.98 |
|
|
Pagerduty (PD) | 2.2 | $2.8M | +25% | 150k | 18.55 |
|
inTEST Corporation (INTT) | 2.0 | $2.6M | +13% | 350k | 7.30 |
|
Bgc Group Com - Class A (BGC) | 2.0 | $2.5M | -15% | 275k | 9.18 |
|
Centerra Gold (CGAU) | 1.9 | $2.5M | +16% | 350k | 7.16 |
|
Barrick Gold Corp (GOLD) | 1.9 | $2.5M | 125k | 19.89 |
|
|
Evolus (EOLS) | 1.9 | $2.4M | 150k | 16.20 |
|
|
Ark Restaurants (ARKR) | 1.9 | $2.4M | 200k | 11.99 |
|
|
Sabre (SABR) | 1.8 | $2.4M | +8% | 650k | 3.67 |
|
Iovance Biotherapeutics (IOVA) | 1.8 | $2.3M | 250k | 9.39 |
|
|
Viatris (VTRS) | 1.8 | $2.3M | 200k | 11.61 |
|
|
Republic Bancorp Com - Class A (RBCAA) | 1.8 | $2.3M | 35k | 65.30 |
|
|
Brookline Ban (BRKL) | 1.8 | $2.3M | +18% | 225k | 10.09 |
|
Jazz Pharmaceuticals (JAZZ) | 1.7 | $2.2M | +60% | 20k | 111.41 |
|
CVS Caremark Corporation (CVS) | 1.7 | $2.2M | +16% | 35k | 62.88 |
|
Park Hotels & Resorts Inc-wi (PK) | 1.6 | $2.1M | +200% | 150k | 14.10 |
|
Coherus Biosciences (CHRS) | 1.6 | $2.1M | +81% | 2.0M | 1.04 |
|
Organon & Co (OGN) | 1.5 | $1.9M | -20% | 100k | 19.13 |
|
First Financial Corporation (THFF) | 1.4 | $1.9M | +6% | 43k | 43.85 |
|
Walgreen Boots Alliance (WBA) | 1.4 | $1.8M | +33% | 200k | 8.96 |
|
Pfizer (PFE) | 1.3 | $1.7M | +20% | 60k | 28.94 |
|
Copa Holdings Sa Com - Class A (CPA) | 1.3 | $1.6M | NEW | 18k | 93.84 |
|
Cohu (COHU) | 1.2 | $1.5M | +100% | 60k | 25.70 |
|
Freeport-mcmoran Com - Class B (FCX) | 1.2 | $1.5M | NEW | 30k | 49.92 |
|
Xoma Corp Del (XOMA) | 1.1 | $1.5M | 55k | 26.48 |
|
|
Warner Bros. Discovery (WBD) | 1.1 | $1.4M | -12% | 175k | 8.25 |
|
Service Pptys Tr Com Sh Ben Int (SVC) | 1.1 | $1.4M | 300k | 4.56 |
|
|
Herc Hldgs (HRI) | 1.0 | $1.3M | NEW | 8.0k | 159.43 |
|
AMCON Distributing (DIT) | 0.9 | $1.2M | 8.3k | 144.95 |
|
|
Cytosorbents (CTSO) | 0.9 | $1.2M | -5% | 800k | 1.50 |
|
ACADIA Pharmaceuticals (ACAD) | 0.8 | $1.1M | +75% | 70k | 15.38 |
|
Perrigo Company (PRGO) | 0.8 | $1.0M | NEW | 40k | 26.23 |
|
Pan American Silver Corp Can (PAAS) | 0.8 | $1.0M | -33% | 50k | 20.87 |
|
Heron Therapeutics (HRTX) | 0.8 | $995k | +66% | 500k | 1.99 |
|
Nektar Therapeutics (NKTR) | 0.8 | $975k | 750k | 1.30 |
|
|
Battalion Oil Corp (BATL) | 0.7 | $934k | 140k | 6.67 |
|
|
Coya Therapeutics (COYA) | 0.7 | $929k | +44% | 144k | 6.45 |
|
Atea Pharmaceuticals (AVIR) | 0.7 | $905k | 270k | 3.35 |
|
|
Newell Rubbermaid (NWL) | 0.6 | $768k | -42% | 100k | 7.68 |
|
Eledon Pharmaceuticals (ELDN) | 0.5 | $685k | +71% | 275k | 2.49 |
|
Lantern Pharma (LTRN) | 0.5 | $679k | +131% | 185k | 3.67 |
|
Curis (CRIS) | 0.5 | $647k | 120k | 5.39 |
|
|
Compass Therapeutics (CMPX) | 0.4 | $570k | 310k | 1.84 |
|
|
Edesa Biotech (EDSA) | 0.4 | $490k | +22% | 110k | 4.45 |
|
Femasys (FEMY) | 0.4 | $472k | 425k | 1.11 |
|
|
First Horizon National Corporation (FHN) | 0.3 | $388k | NEW | 25k | 15.53 |
|
Assertio Holdings (ASRT) | 0.3 | $384k | -7% | 325k | 1.18 |
|
Pieris Pharmaceuticals (PIRS) | 0.3 | $373k | NEW | 23k | 16.58 |
|
Cadence Bank (CADE) | 0.2 | $319k | 10k | 31.85 |
|
|
Elicio Therapeutics (ELTX) | 0.2 | $252k | 50k | 5.03 |
|
|
Kronos Bio (KRON) | 0.2 | $200k | +48% | 200k | 1.00 |
|
Os Therapies Incorporated | 0.1 | $140k | NEW | 50k | 2.80 |
|
Cognition Therapeutics (CGTX) | 0.1 | $117k | +25% | 250k | 0.47 |
|
Past Filings by CM Management
SEC 13F filings are viewable for CM Management going back to 2020
- CM Management 2024 Q3 filed Nov. 12, 2024
- CM Management 2024 Q2 filed Aug. 1, 2024
- CM Management 2024 Q1 filed May 14, 2024
- CM Management 2023 Q4 filed Feb. 12, 2024
- CM Management 2023 Q3 filed Nov. 7, 2023
- CM Management 2023 Q2 filed Aug. 4, 2023
- CM Management 2023 Q1 filed May 8, 2023
- CM Management 2022 Q4 filed Feb. 9, 2023
- CM Management 2022 Q3 filed Nov. 4, 2022
- CM Management 2022 Q2 filed Aug. 8, 2022
- CM Management 2022 Q1 filed May 9, 2022
- CM Management 2021 Q4 filed Feb. 2, 2022
- CM Management 2021 Q3 filed Nov. 8, 2021
- CM Management 2021 Q2 filed Aug. 10, 2021
- CM Management 2021 Q1 filed May 12, 2021
- CM Management 2020 Q4 filed Feb. 4, 2021